Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Aug 2;12(8):2017-2024.
doi: 10.1080/21645515.2015.1127489. Epub 2016 Apr 15.

Impact of a multi-component antenatal vaccine promotion package on improving knowledge, attitudes and beliefs about influenza and Tdap vaccination during pregnancy

Allison T Chamberlain  1 , Katherine Seib  2 , Kevin A Ault  3 , Eli S Rosenberg  1 , Paula M Frew  4 , Marielysse Cortes  5 , Ellen A S Whitney  1 , Ruth L Berkelman  1 , Walter A Orenstein  2 , Saad B Omer  5
Affiliations
Randomized Controlled Trial

Impact of a multi-component antenatal vaccine promotion package on improving knowledge, attitudes and beliefs about influenza and Tdap vaccination during pregnancy

Allison T Chamberlain et al. Hum Vaccin Immunother. .

Abstract

Objective: Understanding whether interventions designed to improve antenatal vaccine uptake also change women's knowledge about vaccination is critical for improving vaccine coverage. This exploratory study evaluates the effectiveness of a multi-component influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccine promotion package on improving women's knowledge, attitudes and beliefs toward antenatal vaccination.

Study design: In 2012/2013 a cluster-randomized trial was conducted to test the effectiveness of a vaccine promotion package on improving antenatal vaccine coverage. Participants included 325 unvaccinated pregnant women from 11 obstetric practices in Georgia. Eleven health beliefs measures were assessed at baseline and 2-3 months post-partum. Outcomes were differences in proportions of women citing favorable responses to each measure between study groups at follow-up.

Results: Women enrolled in their third trimester had a higher probability of asking family members to vaccinate to protect the infant if they were in the intervention group versus the control group (36% vs. 22%; risk ratio [RR] = 1.65, 95% confidence interval [CI]: 1.21, 2.26). A similar association was not observed among women enrolled before their third trimester (39% vs. 44%; RR = 0.93, 95% CI: 0.50, 1.73). There were no other significant differences at follow-up between study groups.

Conclusions: While exposure to the intervention package may have raised awareness that vaccinating close contacts can protect an infant, there is little evidence that the package changed women's attitudes and beliefs toward antenatal vaccination. Future research should ensure adequate exposure to the intervention and consider study design aspects including power to assess changes in secondary outcomes, discriminatory power of response options, and social desirability bias. This study is registered with clinicaltrials.gov, study ID NCT01761799.

Keywords: Tdap; antenatal vaccination; influenza; randomized clinical trial.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention Influenza Vaccination Coverage Among Pregnant Women — 2011–12 Influenza Season, United States. Morb Mortal Wkly Rep 2012; 61(38):758-763 - PubMed
    1. Centers for Disease Control and Prevention Influenza vaccination coverage among pregnant women - United States, 2012 – 2013 influenza season. Morb Mortal Wkly Rep 2013; 62 (38):787-792 - PMC - PubMed
    1. Ahluwalia IB, Ding H, D'Angelo D, Shealy KH, Singleton JA, Liang J, Rosenberg KD; Centers for Disease Control and Prevention (CDC) . Tetanus, Diphtheria, Pertussis Vaccination Coverage Before, During and After Pregnancy – 16 States and New York City, 2011. Morb Mortal Wkly Rep 2015; 64 (19):522-526 - PMC - PubMed
    1. Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway AL, Klein NP, Cheetham TC, Hambidge SJ, Vellozzi C, Nordin JD. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites. Preventive Medicine 2014; 67(0):316-319; PMID:24952094; http://dx.doi.org/10.1016/j.ypmed.2014.05.025 - DOI - PubMed
    1. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women — advisory committee on immunization practices (ACIP), 2012. Morb Mortal Wkly Rep 2013; 62(07):131-135 - PMC - PubMed

Publication types

Substances

Associated data